New hope for young japanese patients with rare brain tumors?

This early-stage study is testing a drug called tovorafenib in Japanese children, adolescents, and young adults (ages 6 months to 25 years) with a specific type of brain tumor (low-grade glioma) that has come back or is growing. The main goals are to check the drug's safety and how the body processes it. All participants will take the drug once a week by mouth for up to 2 years, and the study will also look at whether the drug can shrink the tumors.